Ticker Details
Taysha Gene Therapies, Inc.
IPO Date:	September 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.33B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.27 | 4.09%
Avg Daily Range (30 D):	$0.13 | 2.91%
Avg Daily Range (90 D):	$0.14 | 2.96%

Institutional Daily Volume
Avg Daily Volume:	1.6M
Avg Daily Volume (30 D):	2.37M
Avg Daily Volume (90 D):	2.36M

Trade Size
Avg Trade Size (Sh.):	194
Avg Trade Size (Sh.) (30 D):	140
Avg Trade Size (Sh.) (90 D):	134

Institutional Trades
Total Institutional Trades:	623
Avg Institutional Trade:	$1.89M
Avg Institutional Trade (30 D):	$1.73M
Avg Institutional Trade (90 D):	$1.91M
Avg Institutional Trade Volume:	.54M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.34M
Avg Closing Trade (30 D):	$1.99M
Avg Closing Trade (90 D):	$2.12M
Avg Closing Volume:	597.63K

News

Apr 3, 2026 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Mar 19, 2026 @ 12:00 PM Taysha Gene Therapies Reports Full-Year 2025 Finan... Source: Not Specified

Feb 6, 2026 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Oct 17, 2025 @ 1:00 PM Sandhoff Disease Treatment Market Size Projects US... Source: Towards Healthcare

Sep 5, 2025 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Hayleigh Collins

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.34	$-.08	$-.34
Diluted EPS	$-.34	$-.08	$-.34
Revenue	$9.77M	$5.49M	$9.77M
Gross Profit
Net Income / Loss	$-109M	$-27.85M	$-109M
Operating Income / Loss	$-110.5M	$-28.3M	$-110.5M
Cost of Revenue
Net Cash Flow	$180.9M	$22.59M	$180.9M
PE Ratio